New York City

New York Duo Charged in Multiyear HIV Medication Fraud and Identity Theft Scheme

AI Assisted Icon
Published on June 30, 2025
New York Duo Charged in Multiyear HIV Medication Fraud and Identity Theft SchemeSource: U.S. Attorney's Office

Two New York men have been charged in a complex scheme involving HIV medication fraud and identity theft. The defendants, identified as Josue Torres and Anthony Guerra, are accused of manipulating e-prescribing platforms to issue fraudulent prescriptions for costly medications using stolen identities of doctors and patients, according to a statement from federal prosecutors. Both were reportedly arrested on June 17, and have since faced a magistrate judge, the U.S. Attorney's Office for the Southern District of New York revealed.

The allegations against the suspects highlight areas of healthcare fraud where life-saving medications are allegedly misused for criminal purposes. "By feeding the black market for prescription medications, the defendants' alleged crimes endangered the safety of patients and undermined the integrity of our health care system," U.S. Attorney Jay Clayton said in the press release. The two men allegedly leveraged copay assistance programs to minimize out-of-pocket expenses, turning a significant profit by reselling these medications on the black market. An elaborate operation that spanned roughly four years, involved roughly 693 fraudulent prescriptions using the identities of 18 targeted medical practitioners.

The scheme's far-reaching implications are severe, as it not only defrauded pharmacies and insurers but potentially put patients' health at risk by diverting critical medications. The FBI has stressed the impact of such fraudulent activity, with Assistant Director in Charge Christopher G. Raia saying, "These defendants allegedly exploited private medical information of both practitioners and patients to perpetuate this elaborate scheme," in a statement obtained by the U.S. Attorney's Office. Detailed within the complaint are instances where Torres accessed unauthorized e-prescribing platforms to issue fraudulent prescriptions, subsequently picked up at pharmacies or shipped to various addresses. This operation managed to accrue medications worth approximately $2.6 million.

The Department of Justice's announcement aligns with a broader enforcement action, targeting healthcare fraud and illegal drug diversion on a national scale. As part of this concerted crackdown, 324 defendants were charged relating to schemes that amounted to over $14.6 billion in false billings. In connection with this initiative, authorities seized upwards of $245 million in cash and luxury assets, signaling a robust effort to dismantle networks that ply their trade in the currency of deceit and exploitation. Among the seized assets were luxury vehicles and cash. Torres and Guerra, if convicted, could face lengthy sentences—one count can carry up to 20 years in prison.

As with all U.S. legal proceedings, the charges laid out remain accusations, and the defendants hold the right to be presumed innocent until proven guilty. The case is currently managed by the Office’s General Crimes Unit, with Assistant U.S. Attorney Henry Ross at the helm of the prosecution.